SESN Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Sesen Bio Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 03/7/2023 01:00 AM ET
Sesen Bio Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/2/2023 | Elly Ryu | Insider | Sell | 864 | $11.80 | $10,195.20 | 7,431 | |
| 3/2/2023 | Glen C. Macdonald | CTO | Sell | 8,518 | $11.80 | $100,512.40 | 10,337 | |
| 3/2/2023 | Mark Sullivan | General Counsel | Sell | 10,960 | $11.80 | $129,328.00 | 9,935 | |
| 3/2/2023 | Monica Forbes | CFO | Sell | 17,292 | $11.80 | $204,045.60 | 16,306 | |
| 3/2/2023 | Thomas R. Cannell | CEO | Sell | 24,374 | $11.80 | $287,613.20 | 17,207 | |
| 2/21/2023 | Elly Ryu | Insider | Sell | 357 | $11.80 | $4,212.60 | 8,295 | |
| 2/21/2023 | Glen C. Macdonald | CTO | Sell | 1,296 | $11.80 | $15,292.80 | 14,149 | |
| 2/21/2023 | Mark Sullivan | General Counsel | Sell | 1,991 | $11.80 | $23,493.80 | 14,984 | |
| 2/21/2023 | Monica Forbes | CFO | Sell | 3,093 | $11.80 | $36,497.40 | 24,019 | |
| 2/21/2023 | Thomas R. Cannell | CEO | Sell | 2,686 | $11.80 | $31,694.80 | 27,653 | |
Sesen Bio Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/13/2023 | BML Capital Management LLC | 8,227,969 | $5.02M | 4.8% | N/A | 4.058% |  |
| 2/8/2023 | Cambridge Investment Research Advisors Inc. | 94,821 | $58K | 0.0% | -29.7% | 0.047% |  |
| 2/2/2023 | Blodgett Wealth Advisors LLC | 600,000 | $0.37M | 0.4% | +83.0% | 0.296% |  |
| 11/10/2022 | Connor Clark & Lunn Investment Management Ltd. | 142,751 | $61K | 0.0% | N/A | 0.072% |  |
| 11/7/2022 | Virtu Financial LLC | 72,808 | $31K | 0.0% | N/A | 0.037% |  |
| 7/28/2022 | Privium Fund Management UK Ltd | 331,392 | $0.27M | 0.3% | N/A | 0.166% |  |
| 7/22/2022 | Stratos Wealth Partners LTD. | 413,130 | $0.34M | 0.0% | +6.0% | 0.207% |  |
| 7/13/2022 | Cambridge Investment Research Advisors Inc. | 134,921 | $0.11M | 0.0% | +41.6% | 0.068% |  |
| 5/3/2022 | Venture Visionary Partners LLC | 65,347 | $39K | 0.0% | +44.1% | 0.033% |  |
| 5/2/2022 | Allspring Global Investments Holdings LLC | 50,012 | $30K | 0.0% | N/A | 0.025% |  |
| 4/26/2022 | Stratos Wealth Partners LTD. | 389,565 | $0.24M | 0.0% | +33.6% | 0.195% |  |
| 2/14/2022 | Parallax Volatility Advisers L.P. | 72,340 | $59K | 0.0% | N/A | 0.036% |  |
| 2/9/2022 | Principal Financial Group Inc. | 57,935 | $47K | 0.0% | -88.9% | 0.029% |  |
| 2/8/2022 | ProShare Advisors LLC | 72,068 | $59K | 0.0% | +184.3% | 0.036% |  |
| 2/2/2022 | Blodgett Wealth Advisors LLC | 327,900 | $0.27M | 0.2% | N/A | 0.164% |  |
| 1/14/2022 | Stratos Wealth Partners LTD. | 291,500 | $0.24M | 0.0% | -25.0% | 0.146% |  |
| 11/16/2021 | Squarepoint Ops LLC | 87,070 | $69K | 0.0% | N/A | 0.044% |  |
| 11/16/2021 | Two Sigma Advisers LP | 2,270,118 | $1.80M | 0.0% | -17.9% | 1.138% |  |
| 11/16/2021 | Two Sigma Investments LP | 2,773,393 | $2.20M | 0.0% | -12.0% | 1.390% |  |
| 11/16/2021 | Two Sigma Securities LLC | 130,645 | $0.10M | 0.0% | N/A | 0.065% |  |
| 11/15/2021 | Marshall Wace LLP | 78,414 | $62K | 0.0% | N/A | 0.039% |  |
| 11/12/2021 | Renaissance Technologies LLC | 1,569,685 | $1.25M | 0.0% | +23.7% | 0.787% |  |
| 11/12/2021 | Geode Capital Management LLC | 2,620,990 | $2.08M | 0.0% | -8.1% | 1.337% |  |
| 11/9/2021 | Barclays PLC | 83,241 | $66K | 0.0% | +244.0% | 0.042% |  |
| 11/9/2021 | BlackRock Inc. | 10,935,322 | $8.67M | 0.0% | +2.6% | 5.579% |  |
| 11/8/2021 | State Board of Administration of Florida Retirement System | 86,564 | $69K | 0.0% | N/A | 0.044% |  |
| 11/5/2021 | Advisor Group Holdings Inc. | 36,650 | $29K | 0.0% | +45.7% | 0.019% |  |
| 11/4/2021 | Deutsche Bank AG | 874,335 | $0.69M | 0.0% | -25.7% | 0.446% |  |
| 11/2/2021 | Cambridge Investment Research Advisors Inc. | 103,116 | $82K | 0.0% | +16.6% | 0.053% |  |
| 11/2/2021 | New York State Common Retirement Fund | 122,467 | $97K | 0.0% | -16.3% | 0.062% |  |
| 11/1/2021 | SG Americas Securities LLC | 67,856 | $54K | 0.0% | N/A | 0.035% |  |
| 10/29/2021 | Commonwealth Equity Services LLC | 44,923 | $35K | 0.0% | +320.9% | 0.023% |  |
| 10/29/2021 | Vontobel Holding Ltd. | 115,000 | $91K | 0.0% | +9.5% | 0.059% |  |
| 10/22/2021 | Strs Ohio | 95,900 | $76K | 0.0% | +142.8% | 0.049% |  |
| 10/19/2021 | Stratos Wealth Partners LTD. | 388,900 | $0.31M | 0.0% | +10.3% | 0.198% |  |
| 9/3/2021 | Parametric Portfolio Associates LLC | 83,988 | $0.39M | 0.0% | N/A | 0.043% |  |
| 8/16/2021 | Goldman Sachs Group Inc. | 59,477 | $0.28M | 0.0% | -59.5% | 0.030% |  |
Data available starting January 2016
Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.
Read More on Sesen Bio
Today's Range
Now: N/A
52 Week Range
Now: N/A
Volume
93,330 shs
Average Volume
1,067,298 shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.83